Nykredit A/S’s Novo Nordisk NVO Stock Holding History

Nykredit A/S’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$289K	Buy	+6,026	New	+$259K	﹤0.01%	887

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nykredit A/S's NVO Position: Q2 2026 in Review

Nykredit A/S opened a new position in Novo Nordisk (NVO) in Q2 2026: 6,026 shares worth $289K. The stake represents ﹤0.01% of the portfolio and ranks #887 among its holdings.

1,138 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Nykredit A/S held 6,026 shares of Novo Nordisk worth $289K as of Q2 2026.
Novo Nordisk was a new Nykredit A/S position in Q2 2026.
Novo Nordisk made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #887 holding.
1,138 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.